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Abstract 
The lytic phage ST79 of Burkholderia pseudomallei can lyse a broad range of its host including antibiotic resistant iso-
lates from within using a set of proteins, holin, lysB, lysC and endolysin, a peptidoglycan (PG) hydrolase enzyme. The 
phage ST79 endolysin gene identified as peptidase M15A was cloned, expressed and purified to evaluate its poten-
tial to lyse pathogenic bacteria. The molecular size of the purified enzyme is approximately 18 kDa and the in silico 
study cited here indicated the presence of a zinc-binding domain predicted to be a member of the subfamily A of a 
metallopeptidase. Its activity, however, was reduced by the presence of Zn2+. When Escherichia coli PG was used as a 
substrate and subjected to digestion for 5 min with 3 μg/ml of enzyme, the peptidase M15A showed 2 times higher 
in lysis efficiency when compared to the commercial lysozyme. The enzyme works in a broad alkaligenic pH range of 
7.5–9.0 and temperatures from 25 to 42 °C. The enzyme was able to lyse 18 Gram-negative bacteria in which the outer 
membrane was permeabilized by chloroform treatment. Interestingly, it also lysed Enterococcus sp., but not other 
Gram-positive bacteria. In general, endolysin cannot lyse Gram-negative bacteria from outside, however, the cationic 
amphipathic C-terminal in some endolysins showed permeability to Gram-negative outer membranes. Genetically 
engineered ST79 peptidase M15A that showed a broad spectrum against Gram-negative bacterial PG or, in combina-
tion with an antibiotic the same way as combined drug methodology, could facilitate an effective treatment of severe 
or antibiotic resistant cases.
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Introduction
A bacteriophage or phage is the virus of bacteria that is 
very specific to its host. It can replicate, multiply after 
transfection and either lyse the host or become inte-
grated into its genome (Golkar et  al. 2014). Eastern 
Europe such as Poland and Georgia reported the phage 
as an alternative therapy for infectious diseases (Abedon 
et  al. 2011). Phage therapy has also been evaluated in 
the United States (Ho 2001). The discovery of antibiot-
ics changed the paradigm of curing infectious diseases 
and helped protect enormous numbers of people who 
suffered from bacterial infections in the twentieth cen-
tury, however, the numbers of antibiotic-resistant bacte-
ria have also increased (Golkar et al. 2014). Even though 
the post-antibiotic era is not at hand, the use of broad-
spectrum antibiotics has proven to disturb the beneficial 
bacterial community in humans and animals, especially 
gut microbiota, that affect immunity (O’Hara and Shana-
han 2006; Round and Mazmanian 2009). Therefore, the 
use of phages as an alternative treatment came under the 
spotlight again because the phage is highly specific, can 
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overcome antibiotic resistant bacteria and are available in 
large quantities in nature.
The enzymes related to the lysis mechanism of the 
phages that are used to lyse the bacterial host during the 
release of their progeny have been studied and revealed 
the classical holin-endolysin lysis system found in phages 
of both Gram-positive and Gram-negative bacteria 
(Young et  al. 2000). Holin is used to make pores in the 
cytoplasmic membrane that assists endolysin to access 
and cleave peptidoglycan to lyse the bacteria from the 
inside out. In addition, some phages of Gram-negative 
bacteria also have Rz/Rz1 or lysB/lysC accessory proteins 
that help in the lysis of the process (Berry et  al. 2008). 
Endolysins have been considered as a new class of anti-
biotics as they can destroy the peptidoglycan (PG) of 
Gram-positive bacterial cell walls. Endolysin has five spe-
cific activities on PG which are muramidase (lysozyme), 
transglycosylase, glucosaminidase that digests N-acetyl-
muramic acids (NAM) and N-acetylglucosamine (NAG), 
amidase that digests NAM and peptides and endopepti-
dases digested within the peptide chain of PG (Borys-
owski et al. 2006). The enzymes or the phages themselves 
are extensively applied in several fields, for example, the 
food industry and biological control of unwanted bac-
teria (Ruyter et  al. 1997) including pathogenic bacteria 
in medicine as it shows neither toxicity nor stimulates 
hyperimmune sera in the mouse model (Jado et al. 2003).
Burkholderia pseudomallei is a Gram-negative soil 
bacterium that causes severe septic infectious disease 
called melioidosis. The disease can be found in both 
humans and animals in endemic areas (Leelarasamee and 
Bovornkitti 1989). This pathogenic bacterium is intrinsi-
cally resistant to several antibiotics and it can produce 
high levels of biofilms that protect the bacterium from 
the killing by either antibiotics or the host immune 
response (Sawasdidoln et  al. 2010; Pibalpakdee et  al. 
2012; Mongkolrob et  al. 2015). The drug of choice is a 
third generation cephalosporin such as ceftazidime that 
needs long-term treatment to prevent relapse. Currently, 
there is no commercial vaccine available (Limmathurot-
sakul et al. 2015). Phages that have shown some specific-
ity in lysing B. pseudomallei have been reported (Sariya 
et al. 2006; Yordpratum et al. 2011; Gatedee et al. 2011; 
Kvitko et al. 2012; Guang-Han et al. 2016). The genome of 
ST79, a novel lytic phage that lyses B. pseudomallei was 
sequenced and submitted to GenBank (GI:509141608) 
(manuscript in preparation). The lysis cassette of ST79 
was also characterized (Khakhum et  al. 2016) and its 
modified phages were shown to lyse a wide range of B. 
pseudomallei isolates and could significantly reduce bio-
film formation of the bacteria especially at the early stage 
of attachment (Kulsuwan et al. 2015).
In this study, the peptidase M15A, known as endolysin 
or peptidoglycan hydrolase from the ST79 lytic phage 
that could lyse a broad spectrum of B. pseudomallei and 
other Gram-negative bacteria from within was cloned, 
expressed and characterized. More information on the 
enzymes and phages themselves could facilitate the appli-
cation of them as adjunct standard antibiotic therapy for 
B. pseudomallei.
Materials and methods
Bacterial strains and ST79 phage
Burkholderia pseudomallei strain P37 was isolated from 
a blood sample from a patient admitted to Srinagarind 
Hospital, Faculty of Medicine, Khon Kaen University, 
Thailand. The B. pseudomallei lytic phage ST79, iso-
lated from soil in the northeast of Thailand, was used as 
a source of the peptidase M15A for cloning (Yordpra-
tum et  al. 2011). Escherichia coli BL21 (DE3) was used 
as the host for cloning and protein expression processes 
(Thermo Fisher Scientific, Waltham, MA, USA). Eight-
een Gram-negative bacteria, five of which were E. coli 
host strains; Top10, LMG194 (Invitrogen, CA, USA), 
DH5α, BL21 (DE3) and XL1-Blue (Thermo Fisher Scien-
tific, Waltham, MA, USA), two B. pseudomallei isolates, 
P37 and G1; two Burkholderia mallei isolates, EY2233 
and EY2237; Burkholderia thailandensis UE5 (kindly 
provided by MORU, Mahidol University, Thailand), 
Klebsiella pneumoniae, Vibrio parahaemolyticus, Pseu-
domonas vasculitis, P. aeruginosa, Acinetobacter bau-
mannii, Salmonella gr. D, Shigella gr. D and Citrobacter 
freundii and seven Gram-positive bacteria included Ente-
rococcus sp., Streptococcus epidermidis, Staphylococcus 
aureus, Bacillus sp., Micrococcus sp., β-streptococcus gr. 
B and Corynebacterium diphtheria were obtained from 
the Department of Microbiology, Faculty of Medicine, 
Khon Kaen University, Khon Kaen, Thailand and used 
in this study. All of bacterial strains and ST79 phage 
were deposited in culture collection belonging to World 
Data Centre For Microorganism (WDCM) as MRCKKU 
(registration number 1130). ST79 phage is available for 
research collaborators.
Bioinformatic analysis
The peptidase M15A amino acid sequence 
(YP_008060500.1) from the ST79 phage genome 
(NC_02134.1) was submitted to BLASTP homology 
search (Altschul et al. 1997) in the NCBI database (http://
www.ncbi.nlm.nih.gov/). The peptidase information 
resource and sequence analysis were performed by the 
MEROPS batch Blast tool (Rawlings and Morton 2008). 
The Interproscan 4 software v.4.8 (Zdobnov and Apweiler 
2001) was used to analyze protein functional domains. 
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The protein conserved domain and structure was pre-
dicted using Pfam (Finn et al. 2016) and SWISS-MODEL 
(Biasini et al. 2014).
ST79 phage propagation and DNA extraction
The ST79 lytic phage was propagated in liquid culture 
using B. pseudomallei strain P37 as the propagating 
strain (Yordpratum et  al. 2011). The phage DNA was 
extracted with a phenol–chloroform extraction method 
as described elsewhere (Sambrook and Russell 2001).
Cloning and expression of peptidase M15A and Western 
blot analysis
The peptidase M15A gene was amplified from the ST79 
genomic DNA by the polymerase chain reaction (PCR) 
using in house designed peptidase M15A forward 
primer (5′-TATAAAGAGCTCTATGCAGTTGACGG 
ACCATTTC-3′) with SacI restriction site (under-
lined sequence) and a peptidase M15A reverse primer 
(5′-ATAATAGGTACCTCATGCGCCCACCGTGTA-3′) 
with the KpnI restriction site (underlined sequence). 
The PCR product was cloned into the pQE31 vector 
(Qiagen, Hilden, Germany) containing the N-termi-
nal 6xhistidine tag and transformed into E. coli BL21 
(DE3). E. coli cells containing the recombinant plasmid 
with peptidase M15A gene were propagated in Luria 
and Bertani (LB) medium containing 100  µg/ml ampi-
cillin until mid-exponential phase (OD600  nm =  0.6) and 
induced with 1  mM final concentration of isopropyl-
β-d-thiogalactopyranoside (IPTG) (Sigma, St. Louis, 
Missouri, USA). Cells were further cultured for 4 h and 
collected as a pellet followed by sonication (10 cycles of 
30 s pulses and 30 s rest at 200 Watts in an ice bath, MSE 
Soniprep 150, MSE, London, UK) in 5  ml lysis buffer 
(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole pH 
8.0). The protein supernatant and pellet fractions were 
separated by 15  % SDS-PAGE (Sambrook and Russell 
2001) using the Novex Sharp Pre-Stained Protein Stand-
ard (Thermo Fisher Scientific, Waltham, MA, USA) as 
the protein molecular weight marker, then blotted onto 
nitrocellulose by a semi-dry blotting system (BioRad, CA, 
USA). The proteins on the membrane were detected by 
anti-6X His tag® antibody (HRP) (Abcam, Cambridge, 
UK) and chemiluminescent SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific, 
Waltham, MA, USA).
Protein purification
The recombinant E. coli BL21 (DE3) containing the pepti-
dase M15A gene-plasmid was induced by IPTG and 
the His-tagged proteins inside E. coli cells were purified 
using Ni–NTA agarose (Qiagen, Hilden, Germany) by a 
gravity-flow chromatography method. SDS-PAGE was 
used to analyze the eluted fractions for the 18  kDa of 
the peptidase M15A protein. The fraction containing the 
protein was refolded by buffer exchanging with 25  mM 
sodium acetate buffer, pH 6.5 and filtered through the 
Amicon® Ultra 10  K centrifugal filter device (Millipore, 
Darmstadt, Germany) according to the manufacturer’s 
instructions. The purified protein was quantified by the 
bicinchoninic acid assay (BCA assay) (Thermo Fisher 
Scientific, Waltham, MA, USA) according to the manu-
facturer’s instructions using a Spectronic 20D+ spectro-
photometer (Thermo Fisher Scientific, Waltham, MA, 
USA).
Zymogram analysis
The peptidase M15A enzyme activity was observed using 
zymogram or renaturing SDS-PAGE (Piuri and Hatfull 
2006) with some modifications as follows: An overnight 
culture of E. coli XL1-Blue (0.2  % w/v) was autoclaved 
and added to the SDS-PAGE solution (15 % w/v) before 
polymerization. The purified peptidase M15A enzyme 
was mixed with 2×  sample-refolding buffer (0.5  mM 
Tris–HCl pH 6.8, 20 % glycerol, 0.2 % bromophenol blue), 
then loaded into the SDS-PAGE containing E. coli. After 
electrophoresis, the gel was incubated at 37 °C for 16 h in 
1 % triton X-100, 25 mM Tris–HCl pH 8.5 and washed 
once with water and stained for 3 h with 0.5 % methylene 
blue in 0.01 % KOH. The peptidoglycan hydrolase activ-
ity of peptidase M15A on E. coli lysate was observed as a 
clear zone.
Enzyme activity
The outer membrane of E. coli XL1-Blue was permeabilized 
by chloroform to expose the peptidoglycan for digestion 
as described by Lavigne et  al. (2004) with some modifi-
cations and used as the substrate for peptidase M15A. In 
brief, bacteria were grown until the mid-exponential phase 
(OD600  nm  =  0.6), then centrifuged at 4000g at 4  °C, for 
15 min to collect the cell pellet. The outer membranes were 
permeabilized by chloroform-saturated 0.05  M Tris–HCl 
buffer, pH 7.5 and gently shaken at room temperature for 
45 min. The permeabilized E. coli were then washed, resus-
pended in 10 mM phosphate buffer, pH 8.0 and adjusted to 
OD600 nm = 0.6–1.0. The E. coli suspension of 270 µl was 
added into 96-well BD Falcon microplates (BD Bioscience, 
San Jose, CA, USA), then the purified peptidase M15A 
enzyme was added at the amount of 0.1 (0.3  μg/ml), 0.5 
(1.6 μg/ml), 1 (3 μg/ml) and 5 μg (16 μg/ml) (30 µl) and the 
turbidity reduction at OD600  nm was measured by a Gen5 
microplate reader (Biotek, Vermont, USA) as the kinetic 
assay for 15  min (1  min time intervals). The chicken egg 
white lysozyme (Sigma, St. Louis, Missouri, USA) (3 μg/ml) 
was used as a positive control and 10 mM phosphate buffer, 
pH 8.0, was used as a negative control (Briers et al. 2007a).
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The effect of pH, temperature and divalent metal ions
To evaluate the effect of pH on enzymatic activity, per-
meabilized E. coli XL1-Blue cells were resuspended in 
900  μl of 10  mM citrate buffer for pH 3.0–5.5, 10  mM 
phosphate buffer for pH 6.0–7.0 or 10  mM Tris–HCl 
buffer for pH 7.5–9.0 and then 100 μl of enzyme (5 μg) 
was added. The percentage of OD600  nm reduction was 
determined after incubation at 30  °C for 15  min. The 
effect of temperatures at 25, 30, 37 and 42 °C on enzyme 
activity were tested in the same manner at pH = 8.0.
The effect of metal ion, particularly Zinc, on enzyme 
activity was observed using 100  μl (5  μg) of purified 
peptidase M15A mixed with 900  μl of permeabilized E. 
coli XL1-Blue cells (OD600  nm  ~  1.0) in various concen-
trations of ZnCl2 (5, 10, 50 and 100 μM), MgCl2, MnCl2 
or CaCl2 (100 and 1000  μM). The relative lytic activity 
was calculated as follows: {ΔOD600 nm sample (endoly-
sin added)  −  ΔOD600 nm (buffer only)}/initial OD600 nm 
(Plotka et al. 2015) and compared with the control with-
out metal ions for 100  % of relative activity (Son et  al. 
2012).
Spectrum of antibacterial lytic activity
A total of 18 Gram-negative and seven Gram-positive 
bacteria were tested for the peptidoglycan hydrolase 
spectrums. Gram-negative bacteria were permeabilized 
by chloroform and their peptidoglycans were used as 
substrates for enzyme digestion as previously described 
(Briers et  al. 2007a). For Gram-positives, each strain 
was grown to mid-exponential phase then centrifuged 
at 3000g to collect cell pellets. The pellets were washed 
and resuspended in 10 mM phosphate buffer pH 8.0, the 
OD600  nm to 0.6–1.0 was adjusted. To test the spectrum 
of antimicrobial lytic activity, 5 and 20  μg in 100  μl of 
purified peptidase M15A was added into 900 μl permea-
bilized cell suspensions of Gram-negative or cell suspen-
sion of Gram-positive. The score was estimated from  % 
relative lytic activity after incubation at 30 °C for 15 min. 
The   % relative activity was defined as—(no lytic activ-
ity),  +  (1–30  %), ++  (31–60  %) and +++  (61–100  %) 
(Son et al. 2012).
Statistical analysis
The data of OD600  nm in the turbidity reduction test at 
different pHs and temperatures were analyzed by a Stu-
dent’s t test and with a p value of  <0.05 considered as 
significant.
Results
Peptidase M15A sequence analysis
The protein sequence of peptidase M15A from the 
lytic phage ST79 showed a conserved domain as Pepti-
dase_M15_3 (PF08291) when analyzed by BLASTP and 
Pfam (Fig.  1a). The Interproscan 4 (version 4.8) protein 
functional domain indicated a Hedgehog signaling/DD-
peptidase zinc-binding domain (SSF55166). The SWISS-
MODEL protein structure prediction was matched with 
the 1lbu.1.A template, which was muramoyl-penta-
peptide carboxypeptidase (MEROPS data). When the 
MEROPS batch Blast tool was used to detect peptidases 
and their non-peptidase homologues sequences in ST79 
genome, it showed common amino acids among pepti-
dases found in other bacterial genome, such as: B. glu-
mae, B. thailandensis, B. cenocepacia, Burkholderia sp. 
CCGE1002, Asticcacaulis excentricus and Pseudomonas 
putida but not B. pseudomallei and B. mallei (Fig.  1b). 
This study’s analysis also identified a homologue catalytic 
domain from amino acid positions 3 to 134 (total 132 
residues) with peptidase from P. putida (MER087996). 
The active site residues were located at the trypto-
phan (W117H) position and metal ligands at histidine 
(H77), aspartic acid (D84) and histidine (H119) (Fig. 1c). 
The analysis also indicated the presence of motifs 
HXXXXXXD and WXH, which were typical for pepti-
dase M15 subfamily A.
Expression, purification and zymogram analysis of the 
Peptidase M15A
The peptidase M15A gene was successfully cloned and 
expressed in E. coli BL21 (DE3). The estimated molecu-
lar weight of purified peptidase M15A on SDS-PAGE was 
approximately 18 kDa (with 6xhis tag) (Fig. 2). For zymo-
gram analysis, the peptidase M15A enzyme in the gel 
lysed the peptidoglycan substrate from E. coli in which it 
appeared as a transparent band (Fig. 2).
Lytic activity test
At the concentration of 1.6  μg/ml onward at 5  min of 
digestion, the enzyme reduced the turbidity of permea-
bilized E. coli XL1-Blue more than the lysozyme. When 
longer times of 10 and 15  min were observed, the tur-
bidities from each concentration including lysozyme 
were similar. When the same concentrations of lysozyme 
and purified peptidase M15A (3  μg/ml) were compared 
at 5 min of digestion, the lysozyme gave a 22 % relative 
lytic activity while the peptidase M15A resulted in 52 %. 
The purified peptidase M15A digested the substrate 
approximate 2 times more than the lysozyme at this point 
(Fig. 3).
Effect of pH, temperature and divalent metal ions on the 
enzyme activity
The peptidase M15A showed highest the activity at pH 
7.5–9.0 with relative activity above 60  % (Fig.  4a). The 
enzyme could work in broad temperature ranges of 
25, 30, 37 and 42  °C (Fig.  4b). The enzyme activity was 
Page 5 of 10Khakhum et al. AMB Expr  (2016) 6:77 
decreased when Zn2+ concentrations were increased 
(Fig.  5). On the other hand, the 100  μM of Mg2+ and 
Mn2+ could only increase approximately 10  % of rela-
tive activity. When the 1000 μM concentration of Mg2+ 
and Mn2+ was used, the enzyme activity was reduced to 
50.3 and 65.6 %. The Ca2+ ion showed little effect on the 
enzyme activity as seen by an approximately 6 % increase 
with 100 μM of the ion and a 5 % decrease when 1000 μM 
was used (Table 1).
Spectrum of antibacterial lytic activity
Eighteen chloroform permeabilized Gram-negative and 
seven Gram-positive bacteria were used for susceptibility 
tests against 5 and 20 μg of the peptidase M15A (Table 2). 
The enzyme lysed the peptidoglycan from all Gram-neg-
ative bacteria investigated. The enzyme effectively lysed 
E. coli, K. pneumoniae, Shigella gr. D and C. freundii and 
moderately lysed Burkholderia spp., V. parahaemolyticus, 
P. vasculitis, P. aeruginosa, A. baumannii and Salmonella 
gr. D (36–82 %). For Gram-positive, it only lyzed Entero-
coccus sp. (49 %).
Discussion
The increase in antibiotic-resistant bacteria makes the 
use of possible phage therapy as an alternative treat-
ment for bacterial infections as one of multiple options 
for treatment. Similar to the concept of a mixed viral vac-
cine, phages also could be used as a portion of a cocktail 
for broad host range lysis and more phage could be added 
into suit the resistance situation (Chan et  al. 2013). PG 
is the major component of Gram-positive bacteria and 
also the lining under the outer membrane of Gram-neg-
ative bacteria. Endolysins are a group of PG hydrolyzing 
enzymes well characterized in phages for their function 
on the release of the progeny out of the bacterial host 
during the lytic cycle. The information on the specificity 
of the phage and its enzymes against bacteria could facili-
tate their use safely.
A novel lytic phage ST79 and its modified phage that 
lyses B. pseudomallei has been reported to effectively 
lyse a broad range of the bacterium (Yordpratum et  al. 
2011; Kulsuwan et  al. 2015). ST79 endolysin-like pro-
tein, peptidase M15A, was identified from the phage 
genome sequence and predicted to contain 149 amino 
acids (approximately 16  kDa) with catalytic but not the 
binding domain (Khakhum et al. 2016). This was similar 
to other lysins from phages that infect Gram-negative 
bacterial hosts, which contain single catalytic domains 
with a molecular mass of 15–20 kDa (Nelson et al. 2012). 
Endolysins KZ144 and EL188 from a Pseudomonas 
phage, however, were shown to contain both lytic and 
N-terminal binding domains (Briers et al. 2007b).
Fig. 1 The bioinformatics analysis of ST79 peptidase M15A protein sequence. a The Peptidase_M15_3 conserved domain analyzed using Pfam; 
#HMM: consensus of the Hidden Markov Models (HMMs), Capital letters indicated the most conserved positions, #MATCH: the match between the 
query sequence and the HMM, ‘ + ’ indicates a positive score which can be interpreted as a conservative substitution, #PP: posterior probability, 
which is the degree of confidence in each individual aligned residue, 0 means 0–5 %, 1 means 5–15 % and so on and 9 means 85–95 %, ‘*’ means 
95–100 % posterior probability, #SEQ: query sequence, ‘-’ indicated deletions in the query sequence with respect to the HMM, b Multiple align-
ment of peptidase protein sequences from the MEROPS database showed identity of peptidase M15A sequence from ST79 phage with peptidase 
enzymes from B. glumae, B. thailandensis, B. cenocepacia, Burkholderia spp. CCGE1002, A. excentricus and P. putida using the CLUSTAL X program. Con-
served amino acids of all sequences were marked with an asterisk. c The full amino acids sequence analysis of ST79 peptidase M15A using MEROPS 
batch Blast. The peptidase unit was labeled in green, active site in red, metal ion ligand in orange and the conserved domain in underlined letters
Page 6 of 10Khakhum et al. AMB Expr  (2016) 6:77 
The peptidase M15A amino acid sequence analyzed by 
MEROPS showed a high identity with conserved amino 
acid sequences of the peptidase M15 subfamily A that is 
typical for metallopeptidases with a metal binding part 
(Rawlings and Morton 2008). A similar prediction was 
observed with BLASTP and Pfam results, detecting a 
conserved domain of peptidase M15_3_superfamily. The 
peptidase M15A from ST79 phage has 132 amino acid 
residues with active sites containing a Zn2+ ion-bind-
ing site at the following amino acids: His77, Asp84 and 
His199. The peptidase enzyme of a Streptomyces phage 
also contains His154, Asp161 and His197 of the D-Ala-
D-Ala carboxypeptidase zinc specific cleavage site. 
When the Zn2+ ion was present, the activity of pepti-
dase M15A from ST79 phage was inhibited while that of 
Streptomyces works more effectively (Courvalin 2006). 
Likewise, the Zn2+ inhibition effect is also found in the 
phage T5 endolysin, in which a 10  mM concentration 
completely inactivated the enzyme immediately after 
addition. It was also observed that this specific endolysin 
requires Ca2+ instead of Zn2+ or Mn2+ at the stage of the 
phage developmental cycle (Mikoulinskaia et  al. 2009). 
Activity of the peptidase M15A was inhibited with addi-
tion of 100  μM Zn2+ (10  % of relative activity remain) 
while 100 μM of Mg2+, Ca2+ and Mn2+ caused a slightly 
increased enzyme activity. When 1000  μM of Mg2+, 
Mn2+ and Ca2+ were used, the activity was decreased. 
On the contrary, Zn2+ and Mn2+ are required for full 
enzymatic activity of LysB4 endolysin from the B. cereus-
infecting phage B4 (Son et al. 2012) and this requirement 
is also seen in Ply500 endolysin from the Listeria mono-
cytogenes phages (Loessner et al. 1995).
Characterization of some biochemical properties of the 
peptidase M15A showed a broad range of optimal pHs 
varying from 7.5 to 9.0 (% relative lytic activity  >60  %), 
which is in alkalophilic range similar to other previously 
reported peptidases as observed for phage T5 endolysin 
(optimum pH 8.5) (Mikoulinskaia et al. 2009), lysB4 (pH 
8.0–10.0) (Son et al. 2012), transglycosylase endolysin of 
the phage SPN1S (pH 7.0–10.5), and the highly thermo-
stable Ts2631 amidase endolysin from the Thermus sco-
toductus phage vB_tsc2631 (7.0–11.0) (Plotka et al. 2015). 
The Peptidase M15A worked at 25–37 °C and also 42 °C 
which is the optimum temperature for cultivation of B. 
pseudomallei in the laboratory (Chen et al. 2003; Palasa-
tien et al. 2008). The enzyme from phages mostly works 
in an alkalophilic pH.
In this study, all the chloroform permeabilized Gram-
negative bacteria were prepared and used as a substrate 
to test the specificity of endolysin against PG (Briers et al. 
2007a). The PG from 18 strains of Gram-negative bacte-
ria including drug resistant strains B. pseudomallei G1, 
Fig. 2 The SDS-PAGE analysis of proteins and zymogram analysis 
of the lytic activity of Peptidase M15A against E. coli peptidoglycan. 
The Coomassie Brilliant blue stained SDS-PAGE gel shows protein 
molecular weight marker (M), induced E. coli cells containing pQE31 
vector (lane 1), induced cells containing peptidase M15A/pQE31 
plasmid (lane 2), 5 μg of purified peptidase M15A protein (lane 3) and 
the zymogram that is stained with 0.1 % methylene blue in 0.01 % 
KOH of SDS-PAGE refolding gel (lane 4). The clear lysis of PG substrate 
by the enzyme on zymogram located at the same position of the 
over-expressed protein band in lane 2 and purified enzyme in lane 3. 
The arrow indicates the 18 kDa lytic band of peptidase M15A
Fig. 3 The turbidity reduction curve of peptidase activity against 
chloroform-treated E. coli. The peptidase M15A activity of various 
amounts was used to lyse chloroform E. coli XL1-Blue cell suspen-
sions. The graph of turbidity reduction using peptidase M15A of 
0.3 μg/ml (filled triangle), 1.6 μg/ml (filled circle), 3 μg/ml (open triangle) 
and 16 μg/ml (open circle) were evaluated. Phosphate buffer (filled 
square) was used as a negative control and 3 μg/ml of lysozyme (filled 
diamond) was used as positive control. Each point represents the 
mean of triplicate experiments and error bars indicate the standard 
deviation (SD)
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B. mallei EY2233 can be lysed by ST79 peptidase M15A. 
The enzyme may be more specific to peptidoglycans of 
Gram-negatives as the enzyme can lyse only Enterococ-
cus sp. among eight Gram-positive bacteria tested. The 
amino acid composition and sequence of PG in Gram-
negative bacteria is known to have a low variation and the 
PG type belong to A1γ. Even though PG from C. diphthe-
riae contains A1γ as in Gram-negative bacteria (Schleifer 
and Kandler 1972), its cell wall is distinct from others 
with a predominance of meso-diaminopimelic acid in the 
murein wall and multiple repetitions of arabinogalactan 
(Besserer et al. 2006). The PG is A1γ type, similar to Bacil-
lus sp., but has modification like deacetylation and resists 
lysozyme digestion (Davis and Weiser 2011). Both of them 
were resistant to the ST79 peptidase M15A. For other 
Gram-positive bacteria, S. epidermidis, S. aureus, Micro-
coccus spp. and β- streptococcus group B, their PG belongs 
to the A3α type (Schleifer and Kandler 1972), preventing 
lysis by the peptidase M15A. Interestingly, Enterococcus 
sp., which is a Healthcare–Associated Infections (HAI) 
bacterium, was effectively lysed by ST79 peptidase M15A. 
The enzyme could act on the D-Ala-D-Ala termini of 
Enterococcus cell wall peptidoglycan (Arthur et al. 1996). 
Therefore, the action of the ST79 peptidase M15A may be 
specific to the peptidoglycan type A1γ of Gram-negative 
bacteria and to the Gram-positive Enterococcus sp.
Fig. 4 The effect of pH and temperature on the peptidase M15A lytic activity against E. coli XL1-Blue peptidoglycan. The optical density at 600 nm 
of cell suspensions was used to observe the effects of pH a and temperature b on the peptidase M15A lytic activity against E. coli XL1-Blue pepti-
doglycan. The grey bars show negative controls without enzyme and black bars indicate the reaction with enzyme. p value <0.05 (*) and 0.01 (**) 
indicate the significance. Each column represents the mean of triplicate experiments and error bars indicate SD
Fig. 5 The percentage of E. coli XL1-Blue peptidoglycan reduction 
when treated with peptidase M15A in the presence of Zn2+. The 
effect of Zn2+ on peptidase M15A activity was calculated from the 
difference between optical densities at 600 nm of enzyme treated 
cells and untreated cells. Each column represents the mean of tripli-
cate experiments and error bars indicate SD
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Even though, in general, endolysin cannot attack 
the PG which is located under the outer membrane in 
Gram-negative bacteria, but permeabilized the outer 
membrane for example with 10  mM EDTA in combi-
nation with 50  mg/ml of the Pseudomonas endolysin 
EL188 can decrease the viable P. aeruginosa cells by 3 
or 4 orders of magnitude in 30  min (Briers et  al. 2011). 
Interestingly, LysAB2, the endolysin from A. bauman-
nii phage фAB2 was reported to have an antibacterial 
effect against both Gram-negative (A. baumannii, E. coli, 
Salmonella enterica) and Gram-positive (Streptococcus 
sanguis, S. aureus, B. subtilis) strains (Lai et  al. 2011). 
LysAB2 contains a C-terminal amphipathic region that is 
necessary for the antibacterial activity as also reported in 
the Lys1521 endolysin from a B. amyloliquefaciens phage 
that contains two cationic C-terminal regions. The cati-
onic region was demonstrated to permeabilize the outer 
membrane of P. aeruginosa (Muyombwe et  al. 1999). It 
is therefore possible to genetically engineer endolysin to 
have the cationic C-terminal regions to lyse Gram-neg-
ative bacteria from outside the same way as suggested by 
Nelson et al. (2012).
Lysozyme, also known as muramidase, is a well-known 
endolysin enzyme that is generally used as a standard for 
comparisons of endolysin activity. For example, A. bau-
mannii phage phiAB2 endolysin activity was only 30  % 
activity of chicken egg white lysozyme (Lai et  al. 2011). 
When the ST79 peptidase M15A activity was compared 
with chicken egg white lysozyme, it could reduce PG 
substrate approximately 2 times higher in lysis efficiency 
than lysozyme. Nevertheless, the transglycosylase SPN1S 
endolysin from Salmonella typhimurium-infecting phage 
can reduce 50 % OD of a 1 ml EDTA pretreated cell sus-
pension when only 50 nanograms was used. This phage 
enzyme, therefore, has approximately 30 times higher 
activity than lysozyme (Lim et  al. 2012) and also more 
than ST79 peptidase M15A.
In conclusion, ST79 peptidase M15A is specific to A1γ 
PG and cleaves PG at the peptide chains. The enzyme can 
work in a broad alkaligenic range and temperature, has 
higher activity when compared to lysozyme and is also 
active against a broad range of Gram-negative bacterial 
PG and also Enterococcus sp. that make the enzyme an 
outstanding one for further development. The cationic 
amphipathic C-terminal in some endolysins that showed 
permeability to Gram-negative bacteria may be geneti-
cally engineered into ST79 peptidase M15A and used 
as an adjunct to standard antibiotic therapy for B. pseu-
domallei infection. The combination of a compound that 
permeabilizes B. pseudomallei’s outer membrane with 
the enzyme that attacks PG may provide a more effec-
tive treatment in severe or drug resistant cases. Intensive 
investigation is, however, definitely required.
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